Mereo BioPharma Group plc (ADR)

General ticker "MREO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $254.9M (TTM average)

Mereo BioPharma Group plc (ADR) does not follow the US Stock Market performance with the rate: -28.5%.

Estimated limits based on current volatility of 7.7%: low 0.31$, high 0.36$

Factors to consider:

  • Total employees count: 33 as of 2023
  • Top business risk factors: Geopolitical risks, Limited operating history, Regulatory and compliance, Cybersecurity threats, Market competition
  • Current price 72.0% below estimated low
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [1.19$, 2.74$]
  • 2026-12-31 to 2027-12-31 estimated range: [1.27$, 2.85$]

Financial Metrics affecting the MREO estimates:

  • Positive: with PPE of -26.8 at the end of fiscal year the price was neutral
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Negative: negative Net income
  • Positive: Investing cash flow per share per price, % of -0.01 > -0.60
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Shareholder equity ratio, % of 89.11 > 64.29
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term MREO quotes

Long-term MREO plot with estimates

Financial data

YTD 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.50MM
Operating Expenses $47.36MM $38.76MM
Operating Income $-47.36MM $-38.26MM
Non-Operating Income $4.11MM $-3.62MM
Interest Expense $1.37MM $0.26MM
R&D Expense $20.93MM $17.77MM
Income(Loss) $-43.25MM $-41.88MM
Net Income(Loss)* $-43.25MM $-41.88MM
Stockholders Equity $60.97MM $40.92MM
Assets $76.39MM $45.92MM
Operating Cash Flow $-32.83MM $-30.97MM
Capital expenditure $0.70MM $0.02MM
Investing Cash Flow $-0.70MM $-0.02MM
Financing Cash Flow $46.15MM $0.33MM
Earnings Per Share** $-0.29 $-0.26
Ordinary share to ADR 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.